| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.05 | 0.4 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.15 | 0.4 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |